4.40
前日終値:
$4.392
開ける:
$4.2
24時間の取引高:
5,889
Relative Volume:
0.11
時価総額:
$198.10M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-0.69%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
ZYBT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ZYBT
Zhengye Biotechnology Holding Ltd
|
4.40 | 198.10M | 0 | 0 | 0 | 0.00 |
![]()
ZTS
Zoetis Inc
|
161.68 | 71.94B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.93 | 47.16B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.19 | 46.33B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.48 | 18.69B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
131.25 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Zhengye Biotechnology Holding Ltd (ZYBT) 最新ニュース
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited Closes Initial Public Offering, Raising $6 Million on Nasdaq - Nasdaq
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - Renaissance Capital
Zhengye Biotechnology Holding Ltd (ZYBT) 財務データ
Zhengye Biotechnology Holding Ltd (ZYBT) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):